Subject(s)

COVID-19 , Physicians , COVID-19/complications , Humans , SARS-CoV-2

Subject(s)

Antiviral Agents/therapeutic use , COVID-19/drug therapy , Clinical Trials as Topic , Drug Repositioning , Host-Pathogen Interactions/drug effects , SARS-CoV-2/drug effects , Adenosine Monophosphate/administration & dosage , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/therapeutic use , Administration, Oral , Alanine/administration & dosage , Alanine/analogs & derivatives , Alanine/therapeutic use , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Antibodies, Neutralizing/administration & dosage , Antibodies, Neutralizing/economics , Antibodies, Neutralizing/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , COVID-19/economics , COVID-19/immunology , COVID-19/mortality , COVID-19/virology , COVID-19 Vaccines , Cytidine/analogs & derivatives , Cytidine/therapeutic use , Depsipeptides/pharmacology , Depsipeptides/therapeutic use , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Drug Combinations , Drug Synergism , Esters/pharmacology , Esters/therapeutic use , Guanidines/pharmacology , Guanidines/therapeutic use , Hospitalization , Humans , Hydroxylamines/therapeutic use , Internationality , Lactams/therapeutic use , Leucine/therapeutic use , Mice , National Institutes of Health (U.S.)/organization & administration , Nitriles/therapeutic use , Peptide Elongation Factor 1/antagonists & inhibitors , Peptides, Cyclic/pharmacology , Peptides, Cyclic/therapeutic use , Proline/therapeutic use , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use , RNA-Dependent RNA Polymerase/antagonists & inhibitors

Subject(s)

COVID-19 , Humans , SARS-CoV-2

Subject(s)

COVID-19/immunology , COVID-19/virology , Natural Killer T-Cells/immunology , SARS-CoV-2/immunology , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , COVID-19/prevention & control , COVID-19 Vaccines/immunology , Humans , SARS-CoV-2/chemistry , SARS-CoV-2/genetics

Subject(s)

Science , Artificial Intelligence/ethics , Artificial Intelligence/trends , COVID-19/epidemiology , COVID-19 Vaccines/supply & distribution , Extreme Weather , Humans , Mars , Proteins/chemistry , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Science/trends , United States , United States Food and Drug Administration/organization & administration

Subject(s)

COVID-19 Vaccines/immunology , COVID-19/epidemiology , COVID-19/immunology , Vaccination/statistics & numerical data , COVID-19/mortality , COVID-19/virology , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/supply & distribution , Child , Humans , Research Report , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , SARS-CoV-2/pathogenicity

Subject(s)

Biomedical Research , COVID-19 Vaccines/immunology , COVID-19/epidemiology , COVID-19/virology , SARS-CoV-2/immunology , SARS-CoV-2/pathogenicity , Virology , Basic Reproduction Number , COVID-19/immunology , COVID-19/prevention & control , COVID-19/transmission , COVID-19 Testing , Global Health/statistics & numerical data , Humans , Immunization, Secondary , Internationality , Molecular Epidemiology , Reinfection/immunology , Reinfection/prevention & control , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , United Kingdom/epidemiology

Subject(s)

Dissent and Disputes , Drug Industry , Inventors/legislation & jurisprudence , National Institutes of Health (U.S.) , Patents as Topic/legislation & jurisprudence , Research Personnel/legislation & jurisprudence , /economics , /supply & distribution , Drug Industry/economics , Drug Industry/legislation & jurisprudence , Humans , Inventors/economics , National Institutes of Health (U.S.)/economics , National Institutes of Health (U.S.)/legislation & jurisprudence , Ownership/economics , Ownership/legislation & jurisprudence , Public-Private Sector Partnerships/economics , Public-Private Sector Partnerships/legislation & jurisprudence , Research Personnel/economics , SARS-CoV-2/genetics , United States

Subject(s)

COVID-19 Vaccines/immunology , COVID-19/complications , Acute Disease/epidemiology , COVID-19/epidemiology , COVID-19/physiopathology , COVID-19/prevention & control , COVID-19/rehabilitation , COVID-19 Vaccines/administration & dosage , Chronic Disease/epidemiology , Chronic Disease/prevention & control , Humans , Immunization, Secondary , Neurological Rehabilitation , Uncertainty

Subject(s)

COVID-19 , Physicians , Antiviral Agents/pharmacology , Humans , SARS-CoV-2

Subject(s)

Biomedical Research/organization & administration , Clinical Trials as Topic/organization & administration , Coronavirus Infections/epidemiology , Drug Industry/organization & administration , National Institutes of Health (U.S.)/organization & administration , Osteochondrodysplasias/drug therapy , Pneumonia, Viral/epidemiology , Animals , COVID-19 , COVID-19 Vaccines , Child , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Drug Approval/organization & administration , Humans , Male , Osteochondrodysplasias/psychology , Pandemics , Stress, Psychological , Uncertainty , United States , Viral Vaccines/immunology

Subject(s)

Betacoronavirus/drug effects , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Coronavirus Infections/drug therapy , Drug Industry/methods , Hydroxychloroquine/pharmacology , Hydroxychloroquine/therapeutic use , Pneumonia, Viral/drug therapy , COVID-19 , Coronavirus Infections/virology , Drug Development/methods , Drug Development/organization & administration , Drug Development/trends , Drug Industry/organization & administration , Humans , Pandemics , Patient Selection , Pneumonia, Viral/virology , SARS-CoV-2 , Time Factors , United States , United States Food and Drug Administration/legislation & jurisprudence

Subject(s)

COVID-19 , Thrombosis , Viral Vaccines , COVID-19 Vaccines , Humans , SARS-CoV-2

Subject(s)

COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/supply & distribution , COVID-19/epidemiology , COVID-19/prevention & control , Immunization Programs/organization & administration , Pediatrics/methods , Adolescent , Adult , Age Distribution , COVID-19/complications , COVID-19/transmission , COVID-19 Vaccines/adverse effects , Child , Child, Preschool , Chile/epidemiology , China/epidemiology , Clinical Trials as Topic , Disease Susceptibility/epidemiology , Disease Transmission, Infectious/prevention & control , Female , Humans , Infant , Israel/epidemiology , Male , Malta/epidemiology , Pediatrics/standards , Physical Distancing , Respiratory Syncytial Virus Infections/epidemiology , United Kingdom/epidemiology , United States/epidemiology